ImmunoPrecise Antibodies Ltd.

TSXV:IPA Lagerbericht

Marktkapitalisierung: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ImmunoPrecise Antibodies Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jennifer Bath

Geschäftsführender

CA$1.9m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts34.9%
Amtszeit als Geschäftsführer4.8yrs
Eigentum des Geschäftsführers0.4%
Durchschnittliche Amtszeit des Managements1.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.5yrs

Jüngste Management Updates

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jennifer Bath im Vergleich zu den Einnahmen von ImmunoPrecise Antibodies verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Vergütung im Vergleich zum Markt: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Entschädigung vs. Einkommen: Jennifer's compensation has been consistent with company performance over the past year.

Geschäftsführer

Jennifer Bath

4.8yrs

Amtszeit

CA$1,856,482

Vergütung

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrskeine Datenkeine Daten
Carla Dahl
Vice President of Marketing1.3yrskeine Daten0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno datakeine Daten0.0048%
CA$ 7.8k

1.3yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kkeine Daten
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrskeine Datenkeine Daten
Anna Pettersson
Independent Directorless than a yearCA$75.55kkeine Daten

4.5yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrener Vorstand: IPA's board of directors are considered experienced (4.5 years average tenure).